Uncategorized

In their study of risk factors for MRSA infection, researchers found patients’ age and antibiotic prophylaxis were not significantly associated with the adverse outcome, despite previous medical literature suggesting otherwise, according to a study published in the Journal of Orthopaedic…

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release.

A Jackson Healthcare survey of 1,512 physicians found 82 percent did not receive compensation from prescriptions, lab tests, diagnostic imaging, hospital admissions or facility/surgery fees, according to a company news release.

A study presented at the recent American Pain Society meeting found that tapentadol ER can be used for analgesia in patients with hypertension because it does not significantly affect blood pressure or heart rate, according to a report by Clinical…

A U.S. Judicial Panel has consolidated lawsuits against DePuy on its Pinnacle metal-on-metal hip implant in a Texas federal court, according to a report by Mass Device.

Kensey Nash Corp. announced that it has acquired the assets including the product lines of Synthes' Norian subsidiary for $22 million in cash, according to a report by Reuters.

For every 10 percent increase in high-speed Internet use, admissions to treatment facilities for prescription drug abuse, including painkillers, rose by 1 percent, according to a study in Health Affairs.

Based on findings from a recent study, researchers suggest electronic health records and clinical decision support systems may not significantly improve quality in ambulatory care settings, according to research published in the Archives of Internal Medicine.

A physician from Destin, Fla., has been convicted of healthcare fraud and illegally dispensing prescription drugs, according to a Daily News report. Robert Bourlier, MD, was convicted on 126 counts of illegally prescribing drugs, which eventually led to the death…

Vancomycin, which has experienced increased usage over the past five years, continues to dominate as a first-line treatment of MRSA infections, according to a Decision Resources and Arlington Medical Resources news release.